Page last updated: 2024-11-04

vorinostat and Cardiomegaly

vorinostat has been researched along with Cardiomegaly in 1 studies

Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).

Cardiomegaly: Enlargement of the HEART, usually indicated by a cardiothoracic ratio above 0.50. Heart enlargement may involve the right, the left, or both HEART VENTRICLES or HEART ATRIA. Cardiomegaly is a nonspecific symptom seen in patients with chronic systolic heart failure (HEART FAILURE) or several forms of CARDIOMYOPATHIES.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Renaud, L1
Harris, LG1
Mani, SK1
Kasiganesan, H1
Chou, JC1
Baicu, CF1
Van Laer, A1
Akerman, AW1
Stroud, RE1
Jones, JA1
Zile, MR1
Menick, DR1

Other Studies

1 other study available for vorinostat and Cardiomegaly

ArticleYear
HDACs Regulate miR-133a Expression in Pressure Overload-Induced Cardiac Fibrosis.
    Circulation. Heart failure, 2015, Volume: 8, Issue:6

    Topics: Animals; Cardiomegaly; Cell Culture Techniques; Disease Models, Animal; Fibroblasts; Histone Deacety

2015